ReviewFrontiers in psychology2025
Why clinical neuropsychology matters in schizophrenia care.
Review in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving care for cognitive impairment in schizophrenia: current perspectives and opportunities in Portugal (a consensus development conference).Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive impairments in schizophrenia are widespread, persistent throughout the illness course, and significantly impact quality of life and functional outcomes. Integrating neuropsychological evaluations into routine clinical care is essential for early identification of cognitive impairments. This approach facilitates the implementation of personalized treatment strategies, including tailored neuropsychological rehabilitation, to promote functional recovery. Although recommended by national and international guidelines, many individuals with schizophrenia do not receive neuropsychological assessment. This article emphasizes the integral role of clinical neuropsychology in schizophrenia care, focusing on six key areas: (1) cognitive domains to assess; (2) addressing subjective cognitive complaints; (3) the impact of symptoms, medication, and substance use on cognitive function; (4) test administration and evaluation procedures; (5) the utilization of neuropsychological results and feedback; and (6) the design and implementation of individualized neuropsychological rehabilitation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.